Parkinson's disease and enhanced inflammatory response

被引：126
|
作者：
Stojkovska, Iva [1 ]
Wagner, Brandon M. [1 ]
Morrison, Brad E. [1 ]
机构：
[1] Boise State Univ, Dept Biol Sci, Boise, ID 83725 USA
来源：
EXPERIMENTAL BIOLOGY AND MEDICINE | 2015年 / 240卷 / 11期
关键词：
Parkinson's disease; neuroinflammation; inflammation; disease models; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BLOOD-BRAIN-BARRIER; SYNUCLEIN TRANSGENIC MICE; ALPHA-SYNUCLEIN; MICROGLIAL ACTIVATION; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; MITOCHONDRIAL DYSFUNCTION; INTRANIGRAL INJECTION; INTERFERON-GAMMA;
D O I：
10.1177/1535370215576313
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Parkinson's disease (PD) is the first and second most prevalent motor and neurodegenerative disease, respectively. The clinical symptoms of PD result from a loss of midbrain dopaminergic (DA) neurons. However, the molecular cause of DA neuron loss remains elusive. Mounting evidence implicates enhanced inflammatory response in the development and progression of PD pathology. This review examines current research connecting PD and inflammatory response.
引用
收藏
页码：1387 / 1395
页数：9
相关论文
共 50 条
  • [41] Early approaches of YKL-40 as a biomarker and therapeutic target for Parkinson's disease
    Anwar, Mai M. M.
    Fathi, Mohamed H. H.
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2023, 13 (02) : 85 - 99
  • [42] A link between nanoparticles and Parkinson's disease. Which nanoparticles are most harmful?
    Mohammadipour, Abbas
    Haghir, Hossein
    Bideskan, Alireza Ebrahimzadeh
    REVIEWS ON ENVIRONMENTAL HEALTH, 2020, 35 (04) : 545 - 556
  • [43] The relationship between inflammatory bowel disease and Parkinson's disease: true or fiction?
    Carmona-Abellan, Mar
    Rodriguez-Lago, Iago
    Luis Cabriada, Jose
    Carlos Gomez-Esteban, Juan
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (07) : 886 - 889
  • [44] Anti-Inflammatory and Neuroprotective Effects of PGE2 EP4 Signaling in Models of Parkinson's Disease
    Pradhan, Suraj S.
    Salinas, Kirstie
    Garduno, Alexis C.
    Johansson, Jenny U.
    Wang, Qian
    Manning-Bog, Amy
    Andreasson, Katrin I.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2017, 12 (02) : 292 - 304
  • [45] The role of Tumour Necrosis Factor in neuroinflammation associated with Parkinson's disease and targeted therapies
    Amin, Ruhul
    Quispe, Cristina
    Docea, Anca Oana
    Ydyrys, Alibek
    Kulbayevae, Marzhan
    Dastan, Sevgi Durna
    Calina, Daniela
    Sharifi-Rad, Javad
    NEUROCHEMISTRY INTERNATIONAL, 2022, 158
  • [46] Extracellular Vesicles for the Diagnosis and Treatment of Parkinson's Disease
    Upadhya, Raghavendra
    Shetty, Ashok K.
    AGING AND DISEASE, 2021, 12 (06): : 1438 - 1450
  • [47] Translation Imaging in Parkinson's Disease: Focus on Neuroinflammation
    Belloli, Sara
    Morari, Michele
    Murtaj, Valentina
    Valtorta, Silvia
    Moresco, Rosa Maria
    Gilardi, Maria Carla
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 12
  • [48] The pathogenesis of Parkinson's disease and crosstalk with other diseases
    Liu, Tingting
    Guo, Dingyou
    Wei, Jianshe
    BIOCELL, 2024, 48 (08) : 1155 - 1179
  • [49] Microglia in Parkinson's Disease
    Ho, Margaret S.
    NEUROGLIA IN NEURODEGENERATIVE DISEASES, 2019, 1175 : 335 - 353
  • [50] Parkinson's disease and iron
    Mochizuki, Hideki
    Choong, Chi-Jing
    Baba, Kousuke
    JOURNAL OF NEURAL TRANSMISSION, 2020, 127 (02) : 181 - 187
12345